JaxBio

At JaxBio we develop a simple blood test for fast, cheap and highly sensitive diagnosis of cancer and early detection.

[JaxBio @jaxbio_tech]

Shanah Tovah! 🍎🍯 #JaxBio #CancerResearch #HealthcareInnovation #ShanahTovah #RoshHashanah

[JaxBio @jaxbio_tech]

We’re pleased to welcome Amnon Bar-Lev as Chairman of the Board of JaxBio Technologies.

Former President of Check Point and founder of Alike Health, Amnon brings more than 25 years of leadership experience across technology and digital health.

[JaxBio @jaxbio_tech]

His perspective will be invaluable as JaxBio continues advancing its technology for cancer detection and disease management. Welcome, Amnon - and wishing our team, partners and community a happy, healthy and sweet New Year.

[JaxBio @jaxbio_tech]

Read perspectives from Dr. Abed Agbarya and Prof. Yuval Ebenstein on the work behind this collaboration: https://t.co/kJ8WtdUAf7 #LiquidBiopsy #LungCancer @dianabletter

[JaxBio @jaxbio_tech]

Great @TimesofIsrael feature on JaxBio’s lung-cancer research and its collaboration with @TelAvivUni, Bnai Zion Medical Center and Sheba Medical Center.

[JaxBio @jaxbio_tech]

Proud to share that our LUMEN study with Sheba Medical Center will be presented at #ERS2026 in Barcelona. The study evaluates a blood test for early lung cancer detection, monitoring and treatment response.

https://t.co/laz3K5PYCw

#JaxBio #LungCancer

[JaxBio @jaxbio_tech]

What if a simple blood test could help detect cancer earlier? Our CEO Dr. Shachar Tzirkin spoke with Danny Roup on Israel’s Economy Channel about JaxBio, our technology, early results and the road ahead.

🎥 Watch the full interview: https://t.co/xO6zmJrSZI
#CancerDetection

[JaxBio @jaxbio_tech]

Read the full article (in Hebrew): https://t.co/N87OAsQZiI #LiquidBiopsy #LungCancer #CancerDiagnostics

[JaxBio @jaxbio_tech]

Our co-founder, Prof. Yuval Ebenstein, writes in @Ynet about JaxBio’s sequencing-free approach to blood-based lung cancer detection – using light to identify cancer-associated DNA patterns.

[JaxBio @jaxbio_tech]

At JaxBio, we are working to address this with a blood-based test designed for fast, low-cost and highly sensitive cancer diagnosis. #EarlyDetection #CancerDiagnostics #LiquidBiopsy

[JaxBio @jaxbio_tech]

Early detection can change cancer care – but only if screening can scale.

A test may be highly sensitive, but if it is too expensive, complex or difficult to deploy, its impact will be limited.

[JaxBio @jaxbio_tech]

Supported by the EIC under Horizon Europe. #LungCancer #LiquidBiopsy #HorizonEurope

[JaxBio @jaxbio_tech]

Dr. Ido Dechtman of Sheba Medical Center recently presented results from the LUMEN study at the Israel Society of Pulmonology meeting.

Led by JAXBIO with Sheba and Beilinson, LUMEN is developing a blood-based test for lung cancer detection and monitoring.

[JaxBio @jaxbio_tech]

Thanks to @JustinPetrone for the coverage. https://t.co/xtSAblyD8v #LiquidBiopsy #CancerDiagnostics

[JaxBio @jaxbio_tech]

Excited to share that JaxBio has been featured in @GenomeWeb, highlighting our mission to broaden access to simpler, faster and more affordable DNA methylation-based liquid biopsy testing.

[JaxBio @jaxbio_tech]

We hope this experience is just the first step on her journey toward a future in science. #MakeAWish #MedicalResearch #Biotechnology #LifeSciences #FutureScientist

[JaxBio @jaxbio_tech]

Some days remind us why we do what we do. ❤️

We were proud to welcome Noam to JAXBIO as part of Pfizer’s Make-A-Wish program and give her the chance to experience life as a medical researcher.

[JaxBio @jaxbio_tech]

Read more: https://t.co/EbdGWKoOS7 #LiquidBiopsy #PrecisionOncology #LungCancer #CancerResearch

[JaxBio @jaxbio_tech]

Can liquid biopsy testing become more affordable and scalable?

JaxBio’s peer-reviewed study in npj Precision Oncology reports a sequencing-free cfDNA methylation microarray assay for lung cancer detection, with an estimated $60/sample research workflow.

[JaxBio @jaxbio_tech]

Congratulations to Rita Haldar and the SANGUINE consortium. #HemaChip #LiquidBiopsy @EACRnews

[JaxBio @jaxbio_tech]

Proud to present our scientific poster at #EACR2026, sharing SANGUINE Project results on HemaChip.

The data highlight HemaChip’s potential to classify multiple hematologic cancers using gDNA and cfDNA methylation profiles.